109 related articles for article (PubMed ID: 16998933)
1. Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
Brown EE; Whitby D; Vitale F; Marshall V; Mbisa G; Gamache C; Lauria C; Alberg AJ; Serraino D; Cordiali-Fei P; Messina A; Goedert JJ
Cancer; 2006 Nov; 107(9):2282-90. PubMed ID: 16998933
[TBL] [Abstract][Full Text] [Related]
2. A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
Brown EE; Fallin MD; Goedert JJ; Chen R; Whitby D; Foster CB; Lauria C; Alberg AJ; Messina A; Montella M; Rezza G; Vitale F; Chanock SJ;
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):633-7. PubMed ID: 15767342
[TBL] [Abstract][Full Text] [Related]
3. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
4. Classic Kaposi sarcoma. Which KSHV-seropositive individuals are at risk?
Guttman-Yassky E; Dubnov J; Kra-Oz Z; Friedman-Birnbaum R; Silbermann M; Barchana M; Bergman R; Sarid R
Cancer; 2006 Jan; 106(2):413-9. PubMed ID: 16353205
[TBL] [Abstract][Full Text] [Related]
5. Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.
Brown EE; Fallin D; Ruczinski I; Hutchinson A; Staats B; Vitale F; Lauria C; Serraino D; Rezza G; Mbisa G; Whitby D; Messina A; Goedert JJ; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):926-34. PubMed ID: 16702372
[TBL] [Abstract][Full Text] [Related]
6. Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
Sullivan SG; Hirsch HH; Franceschi S; Steffen I; Amari EB; Mueller NJ; Magouras I; Biggar RJ; Rickenbach M; Clifford GM;
AIDS; 2010 Sep; 24(14):2245-52. PubMed ID: 20543658
[TBL] [Abstract][Full Text] [Related]
7. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
8. Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
Amodio E; Goedert JJ; Barozzi P; Riva G; Firenze A; Bonura F; Viviano E; Romano N; Luppi M
Cancer Sci; 2011 Oct; 102(10):1769-73. PubMed ID: 21740480
[TBL] [Abstract][Full Text] [Related]
9. KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection.
Parisi SG; Boldrin C; Andreis S; Ferretto R; Fuser R; Malena M; Manfrin V; Panese S; Scaggiante R; Dori L; Sarmati L; Biasolo MA; Nicastri E; Andreoni M; Cruciani M; Palù G
J Med Virol; 2011 Mar; 83(3):384-90. PubMed ID: 21264857
[TBL] [Abstract][Full Text] [Related]
10. Host immunogenetics and control of human herpesvirus-8 infection.
Brown EE; Fallin MD; Goedert JJ; Hutchinson A; Vitale F; Lauria C; Giuliani M; Marshall V; Mbisa G; Serraino D; Messina A; Durum S; Whitby D; Chanock SJ;
J Infect Dis; 2006 Apr; 193(8):1054-62. PubMed ID: 16544245
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
12. Intrafamiliar transmission of Kaposi's sarcoma-associated herpesvirus and seronegative infection in family members of classic Kaposi's sarcoma patients.
Mancuso R; Brambilla L; Agostini S; Biffi R; Hernis A; Guerini FR; Agliardi C; Tourlaki A; Bellinvia M; Clerici M
J Gen Virol; 2011 Apr; 92(Pt 4):744-51. PubMed ID: 21216985
[TBL] [Abstract][Full Text] [Related]
13. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
14. Association of clinical progression in classic Kaposi's sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers.
Stratigos AJ; Malanos D; Touloumi G; Antoniou A; Potouridou I; Polydorou D; Katsambas AD; Whitby D; Mueller N; Stratigos JD; Hatzakis A
Arch Dermatol; 2005 Nov; 141(11):1421-6. PubMed ID: 16301389
[TBL] [Abstract][Full Text] [Related]
15. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
16. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
19. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.
Guttman-Yassky E; Kra-Oz Z; Dubnov J; Friedman-Birnbaum R; Segal I; Zaltzman N; Roth T; Schwartz F; Linn S; Rozenman D; David M; Silbermann M; Barchana M; Bergman R; Sarid R
Arch Dermatol; 2005 Nov; 141(11):1429-34. PubMed ID: 16301390
[TBL] [Abstract][Full Text] [Related]
20. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
